Cytotron(R) Granted 'Breakthrough Device Designation' by U.S. FDA for Treatment of Breast, Liver, and Pancreatic Cancers

GAITHERSBURG, Md., Oct. 31, 2019 -- (Healthcare Sales & Marketing Network) -- The Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) granted Shreis Scalene Sciences (Shreis), in Gaithersburg, MD, 'Breakthrough... Devices, Oncology, FDA Shreis Scalene Sciences, CYTOTRON, Quantum Magnetic Resonance

Source: HSMN NewsFeed - October 31, 2019 Category: Pharmaceuticals Source Type: news